190 related articles for article (PubMed ID: 26169900)
1. A Quality by Experimental Design Approach to Assess the Effect of Formulation and Process Variables on the Extrusion and Spheronization of Drug-Loaded Pellets Containing Polyplasdone® XL-10.
Saripella KK; Loka NC; Mallipeddi R; Rane AM; Neau SH
AAPS PharmSciTech; 2016 Apr; 17(2):368-79. PubMed ID: 26169900
[TBL] [Abstract][Full Text] [Related]
2. Use of extrusion aids for successful production of Kollidon
Loka NC; Saripella KK; Pinto CA; Neau SH
Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
[TBL] [Abstract][Full Text] [Related]
3. Development of rapidly dissolving pellets within the Quality by Design approach.
Karatzas AA; Politis SN; Rekkas DM
Drug Dev Ind Pharm; 2017 May; 43(5):770-779. PubMed ID: 27625003
[TBL] [Abstract][Full Text] [Related]
4. Use of coarse ethylcellulose and PEO in beads produced by extrusion-spheronization.
Mallipeddi R; Saripella KK; Neau SH
Int J Pharm; 2010 Jan; 385(1-2):53-65. PubMed ID: 19853027
[TBL] [Abstract][Full Text] [Related]
5. Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters.
Thommes M; Kleinebudde P
AAPS PharmSciTech; 2007 Nov; 8(4):E95. PubMed ID: 18181555
[TBL] [Abstract][Full Text] [Related]
6. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
Mehta S; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
[TBL] [Abstract][Full Text] [Related]
7. Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site-specific release isoniazid pellets.
Pund S; Joshi A; Vasu K; Nivsarkar M; Shishoo C
Int J Pharm; 2010 Mar; 388(1-2):64-72. PubMed ID: 20035851
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of mefenamic acid sustained release matrix pellets.
Ibrahim MA
Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315
[TBL] [Abstract][Full Text] [Related]
9. Analysis of particle kinematics in spheronization via particle image velocimetry.
Koester M; Thommes M
Eur J Pharm Biopharm; 2013 Feb; 83(2):307-14. PubMed ID: 23000404
[TBL] [Abstract][Full Text] [Related]
10. Melt-in-Mouth Multi-particulate System for the Treatment of ADHD: A Convenient Platform for Pediatric Use.
Patadia J; Tripathi R; Joshi A
AAPS PharmSciTech; 2016 Aug; 17(4):878-90. PubMed ID: 26392403
[TBL] [Abstract][Full Text] [Related]
11. Influence of MCC II fraction and storage conditions on pellet properties.
Krueger C; Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
[TBL] [Abstract][Full Text] [Related]
12. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
Verheyen P; Steffens KJ; Kleinebudde P
Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
[TBL] [Abstract][Full Text] [Related]
13. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.
Liew CV; Gu L; Soh JL; Heng PW
Pharm Res; 2005 Aug; 22(8):1387-98. PubMed ID: 16078149
[TBL] [Abstract][Full Text] [Related]
14. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
Drug Dev Ind Pharm; 2002 Apr; 28(4):451-6. PubMed ID: 12056538
[TBL] [Abstract][Full Text] [Related]
15. Use of к-carrageenan, chitosan and Carbopol 974P in extruded and spheronized pellets that are devoid of MCC.
Valle BL; Omwancha WS; Neau SH; Wigent RJ
Drug Dev Ind Pharm; 2016 Nov; 42(11):1903-16. PubMed ID: 27100683
[TBL] [Abstract][Full Text] [Related]
16. Influence of starting material particle size on pellet surface roughness.
Sarkar S; Ang BH; Liew CV
AAPS PharmSciTech; 2014 Feb; 15(1):131-9. PubMed ID: 24198222
[TBL] [Abstract][Full Text] [Related]
17. A protocol for the classification of wet mass in extrusion-spheronization.
Gao Y; Hong Y; Xian J; Lin X; Shen L; Zhang X; Zhang N; Feng Y
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):996-1005. PubMed ID: 23563104
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of formulations for the preparation of pellets with high drug loading by extrusion/spheronization.
Podczeck F; Knight P
Pharm Dev Technol; 2006; 11(3):263-74. PubMed ID: 16895837
[TBL] [Abstract][Full Text] [Related]
19. Effect of common classes of excipients on extrusion-spheronization.
Law MF; Deasy PB
J Microencapsul; 1997; 14(5):647-57. PubMed ID: 9292440
[TBL] [Abstract][Full Text] [Related]
20. Gellan gum and polyvinylpyrrolidone (PVP) as binding agents in extrusion/spheronization pellet formulations.
Barbosa EJ; Ferraz HG
Acta Pharm; 2019 Mar; 69(1):99-109. PubMed ID: 31259713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
